PR
    Pharmacy Remedy

    Lynparza (olaparib) supply for hospitals & distributors

    PARP inhibitor · AstraZeneca (co-commercialised with MSD)

    Lynparza (olaparib) is an oral PARP inhibitor from AstraZeneca and MSD, used in BRCA-mutated and homologous-recombination-deficient cancers. The current presentation is film-coated tablets taken twice daily.

    اقرأ هذه الصفحة بالعربية

    Prescription-only medicine. No prices are published. Supply is to hospitals, distributors, pharmacies and physicians against a valid prescription or purchase order. This page is product information, not medical advice.

    Product facts

    Active substanceolaparib
    ClassPARP inhibitor
    Manufacturer (marketing authorisation holder)AstraZeneca (co-commercialised with MSD)
    RouteOral

    Strengths and presentation

    • 100 mg film-coated tablets
    • 150 mg film-coated tablets (pack of 56)

    Approved indications (EMA / FDA label summary)

    • Ovarian, fallopian tube and primary peritoneal cancer — maintenance in BRCA-mutated or HRD-positive disease (label-dependent)
    • gBRCA-mutated HER2-negative early (adjuvant) and metastatic breast cancer
    • gBRCA-mutated metastatic pancreatic adenocarcinoma — maintenance
    • Metastatic castration-resistant prostate cancer (BRCA / HRR-mutated, or with abiraterone)

    Short label summary only. Approved indications differ by country and line of therapy; the national label in the destination country governs.

    Storage and cold chain

    • Room-temperature product — store as stated on the carton, in the original pack
    • No cold chain required; shipped in tamper-evident, temperature-protected packaging

    How we supply

    • Original manufacturer packs only — sourced from licensed wholesalers in Türkiye and Europe, never repackaged or relabelled.
    • Batch number and expiry confirmed in writing before dispatch; every pack is traceable to its batch.
    • Documents with every consignment: commercial invoice, batch / CoA information from the source, and packing list.
    • Tamper-evident, temperature-protected shipping; no cold chain is required for this product.
    • Named-patient and special-import support: we prepare the paperwork your hospital or importer needs for the local regulator.

    Procurement notes

    Tablets and the older capsule formulation are not interchangeable mg-for-mg. Orders should specify Lynparza film-coated tablets and strength; the standard pack of 56 × 150 mg covers 28 days at the labelled dose.

    Who we supply

    • Hospital pharmacy and procurement departments
    • Licensed pharmaceutical distributors and importers
    • Oncology and haematology centres
    • Treating physicians arranging named-patient supply

    Markets served

    United Arab Emirates, Saudi Arabia, Qatar, Kuwait, Oman, Bahrain and Iraq. Import into each country follows that country's regulator (for example MOHAP / DoH / DHA, SFDA, MoPH, Kuwait MOH, Oman MOH, NHRA) — we work with the receiving institution's import route.

    Frequently asked questions

    Do you supply Lynparza tablets or capsules?

    We source the film-coated tablets (100 mg and 150 mg), which are the current presentation. Tablets and capsules must not be substituted for each other.

    Is Lynparza a cold-chain product?

    No. Lynparza tablets are stored at room temperature as stated on the carton and ship in tamper-evident, temperature-protected packaging.

    Is the Lynparza you supply an original manufacturer pack?

    Yes. We supply Lynparza only in the original AstraZeneca (co-commercialised with MSD) pack, sourced from licensed wholesalers in Türkiye and Europe, never repackaged or relabelled.

    Which documents come with a consignment?

    Commercial invoice, batch / CoA information from the source and a packing list, with batch number and expiry for every pack. Additional documents requested by your importer can be prepared.

    Do you supply the UAE, Saudi Arabia, Qatar, Kuwait, Oman, Bahrain and Iraq?

    Yes — to hospitals, distributors and licensed centres in these countries, through the import or named-patient route accepted by the destination country's regulator.

    How do I get a quote for Lynparza?

    Send a supply inquiry on WhatsApp with strength, quantity, country and institution. We reply with a written quote, availability and expiry; we do not publish prices on the site.

    Send a supply inquiry

    Tell us the product, strength, quantity, destination country and the receiving institution. We reply with availability, batch/expiry and the documentation set — and a written quote. We do not sell to the public.

    Send a supply inquiry

    Other medicines we supply to the Gulf

    Sources

    Reviewed by Pharmacy Remedy Pharmacovigilance & Compliance Desk · Last updated: 2026-11-04